Fennec Pharmaceuticals (FENC) Revenue Growth (1y) (2024 - 2025)
Fennec Pharmaceuticals (FENC) Revenue Growth (1y) (2024 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,380.63 Bn | 66,380.34 Bn | - | - |
| 2 | Nanobiotix | 1,910.39 Bn | 1,910.33 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 470.95 Bn | 466.16 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.76 Bn | 50.58 Bn | 1.41 Bn | 64.03% |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn | 96.43% |
| 10 | Fennec Pharmaceuticals | 295.91 Mn | 259.13 Mn | 12.01 Mn | 73.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 73.84% |
| Sep 30, 2025 | 78.69% |
| Jun 30, 2025 | 32.91% |
| Mar 31, 2025 | -65.52% |
| Dec 31, 2024 | -18.59% |
| Sep 30, 2024 | 7.05% |
| Jun 30, 2024 | 118.41% |
| Mar 31, 2024 | 1,413.24% |